Effectiveness of Tacrolimus Concomitant with Biological Disease-Modifying Anti-Rheumatic Drugs in Patients with Rheumatoid Arthritis.
Kenya TerabeNobunori TakahashiShuji AsaiYuji HiranoYasuhide KanayamaYuichiro YabeTakeshi OguchiTakayoshi FujibayashiHisato IshikawaMasahiro HanabayashiYosuke HattoriMochihito SuzukiKenji KishimotoYoshifumi OhashiTakahiro ImaizumiShiro ImagamaToshihisa KojimaPublished in: Modern rheumatology (2022)
Concomitant TAC with ABT or ETN showed higher retention rates than bDMARDs therapy without TAC or MTX. AEs did not increase over long-term observation.